Research

Hormonal

Insulin resistance (IR) is a primary pathophysiological driver of Type 2 Diabetes Mellitus (T2DM) and metabolic syndrome, and can be effectively screened using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR).

If you are overweight or have a family history of diabetes, ask your doctor to check your Insulin Resistance (IR) using the HOMA-IR index. This involves a simple fasting blood test for glucose and insulin. Identifying IR early allows for lifestyle changes (diet and exercise) to prevent Type 2 Diabetes.

GoodSupportsHIGH confidence
Insulin resistance (IR) has emerged as a major pathophysiological factor in the development and progression of DM since it is evident in susceptible individuals at the early stages of DM, and particularly type 2 DM (T2DM).
Qi Tang et al. · Drug Discoveries & Therapeutics · 2015

Why this rating

Based on a review of multiple large population studies and guidelines, though cut-off values vary.

Source

Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future

Qi Tang et al. · Drug Discoveries & Therapeutics · 2015

DOI 10.5582/ddt.2015.01207

narrative_reviewCited 298×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →